HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Udo Jeschke Selected Research

Paraffin

1/2013Analysis of Epithelial Growth Factor-Receptor (EGFR) Phosphorylation in Uterine Smooth Muscle Tumors: Correlation to Mucin-1 and Galectin-3 Expression.
5/2012Expression of different carbohydrate tumour markers and galectins 1 and 3 in normal squamous and malignant epithelia of the upper aaerodigestive tract.
12/2011Immunolocalization of glycodelin in human adenocarcinoma of the lung, squamous cell carcinoma of the lung and lung metastases of colonic adenocarcinoma.
5/2010Expression of the carbohydrate tumor marker Sialyl Lewis a (Ca19-9) in squamous cell carcinoma of the larynx.
5/2010Determination of glycodelin-A expression correlated to grading and staging in ovarian carcinoma tissue.
5/2010Glycodelin expression in correlation to grading, nodal involvement and steroid receptor expression in human breast cancer patients.
4/2009Immunohistochemical expression of glycodelin in breast cancer correlates with estrogen-receptor alpha and progesterone-receptor A positivity.
9/2008Distribution and maturity of dendritic cells in diseases of insufficient placentation.
9/2008The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO.
7/2007Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $490.00 USD

Udo Jeschke Research Topics

Disease

35Neoplasms (Cancer)
11/2014 - 01/2005
27Breast Neoplasms (Breast Cancer)
11/2014 - 01/2005
20Carcinoma (Carcinomatosis)
10/2014 - 01/2005
12Ovarian Neoplasms (Ovarian Cancer)
02/2013 - 09/2008
11Neoplasm Metastasis (Metastasis)
11/2014 - 01/2005
9Endometrial Neoplasms (Endometrial Cancer)
09/2010 - 07/2007
8Pre-Eclampsia (Preeclampsia)
07/2014 - 12/2005
7Spontaneous Abortion (Miscarriage)
07/2014 - 05/2008
6Adenocarcinoma
12/2011 - 01/2003
5Ductal Carcinoma
04/2014 - 01/2005
5Inflammation
04/2013 - 03/2009
5Endometriosis (Adenomyosis)
03/2013 - 01/2009
5Trophoblastic Neoplasms (Trophoblastic Tumor)
01/2013 - 06/2004
5Fetal Growth Retardation (Intrauterine Growth Retardation)
09/2008 - 12/2005
5Noninfiltrating Intraductal Carcinoma (DCIS)
07/2007 - 01/2005
5Carcinoma in Situ
07/2007 - 03/2005
3Gestational Diabetes (Gestational Diabetes Mellitus)
07/2014 - 08/2010
3Infection
04/2013 - 01/2009
3Choriocarcinoma
06/2012 - 06/2011
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2011 - 05/2005
3Endometrioid Carcinoma
09/2010 - 05/2005
3Hydatidiform Mole (Molar Pregnancy)
12/2008 - 07/2007
3Hemolysis
09/2008 - 11/2006
3HELLP Syndrome
09/2008 - 02/2007
3Hyperplasia
01/2006 - 01/2003
3Polyps
06/2005 - 01/2003
2Circulating Neoplastic Cells
08/2014 - 12/2012
2Lobular Carcinoma
04/2014 - 05/2005
2Leiomyoma (Uterine Fibroids)
01/2013 - 02/2011
2Habitual Abortion (Recurrent Miscarriage)
01/2013 - 12/2010
2Leiomyosarcoma
01/2013 - 02/2011
2Myoma
01/2013 - 02/2011
2Ovarian Diseases (Ovarian Disease)
01/2012 - 01/2012
2Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
08/2010 - 01/2009
2Breast Ductal Carcinoma
07/2007 - 05/2005
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
07/2007 - 05/2005
1Granulosa Cell Tumor
01/2014
1Premature Birth (Birth, Premature)
04/2013

Drug/Important Bio-Agent (IBA)

22ParaffinIBA
01/2013 - 01/2003
15AntigensIBA
05/2013 - 05/2005
13HormonesIBA
04/2014 - 06/2004
11Estrogens (Estrogen)FDA Link
10/2014 - 07/2007
11Inhibins (Inhibin)IBA
09/2010 - 01/2005
10Estrogen Receptor alphaIBA
04/2014 - 12/2005
9Galectin 1 (LGALS1)IBA
07/2014 - 06/2004
9Mucin-1 (CA 15-3 Antigen)IBA
01/2013 - 07/2007
9Monoclonal AntibodiesIBA
05/2012 - 01/2005
9Activins (Activin)IBA
09/2010 - 01/2005
7Cadherins (E-Cadherin)IBA
11/2014 - 05/2005
7Estrogen Receptor betaIBA
04/2014 - 12/2005
7AntibodiesIBA
02/2013 - 05/2005
7Messenger RNA (mRNA)IBA
01/2013 - 03/2005
71-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA
05/2012 - 06/2004
7Steroid Receptors (Steroid Receptor)IBA
05/2010 - 05/2005
5PPAR gammaIBA
03/2014 - 09/2007
5Glycoproteins (Glycoprotein)IBA
01/2013 - 01/2007
5tranilast (N 5')IBA
04/2010 - 01/2003
4Biological Markers (Surrogate Marker)IBA
03/2014 - 01/2012
4GTP-Binding Proteins (G-Protein)IBA
01/2014 - 11/2012
4Estradiol (Estrace)FDA LinkGeneric
01/2013 - 07/2007
45- acetylneuraminyl- 2- 3- galactosyl- 1- 3- (fucopyranosyl- 1- 4)- N- acetylglucosamineIBA
05/2012 - 05/2005
4Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
05/2012 - 07/2007
4Peroxisome Proliferator-Activated Receptors (PPAR)IBA
08/2010 - 12/2008
3Cathepsin DIBA
04/2014 - 05/2005
3Thomsen-Friedenreich antigenIBA
05/2013 - 01/2007
3Galectin 3 (LGALS3)IBA
01/2013 - 02/2011
3Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2013 - 05/2010
3Progesterone Receptors (Progesterone Receptor)IBA
12/2012 - 07/2007
3ProgesteroneFDA LinkGeneric
01/2012 - 07/2007
3inhibin beta A subunitIBA
05/2009 - 01/2005
3progesterone receptor AIBA
04/2009 - 07/2007
35- acetylneuraminyl- (2- 3)- galactosyl- (1- 4)- (fucopyranosyl- (1- 3))- N- acetylglucosamine (sialyl Lewis x)IBA
02/2009 - 05/2005
3EnzymesIBA
09/2008 - 11/2006
2hydrogen sulfite (bisulfite)IBA
10/2014 - 02/2014
2DNA (Deoxyribonucleic Acid)IBA
10/2014 - 02/2014
2Keratins (Keratin)IBA
08/2014 - 01/2008
2GonadotropinsIBA
01/2013 - 01/2012
2Formaldehyde (Formol)FDA Link
01/2013 - 07/2007
2CytokinesIBA
01/2012 - 09/2008
2LH Receptors (LH Receptor)IBA
01/2012 - 05/2011
2Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
12/2011 - 06/2011
2tyrosine receptor (receptor, tyrosine)IBA
12/2011 - 06/2011
2Phosphotransferases (Kinase)IBA
12/2011 - 06/2011
2Immunoglobulin M (IgM)IBA
05/2010 - 05/2005
2inhibin-alpha subunitIBA
05/2009 - 07/2007
2Estrogen ReceptorsIBA
07/2007 - 07/2007
2Hydrocortisone (Cortisol)FDA LinkGeneric
07/2007 - 07/2007
2Biological Tumor Markers (Tumor Markers)IBA
07/2007 - 07/2007
2Nitric Oxide Synthase (NO Synthase)IBA
11/2006 - 12/2005
2TamoxifenFDA LinkGeneric
06/2005 - 01/2003
1saccharide-binding proteinsIBA
07/2014
1CathepsinsIBA
04/2014
1LipocalinsIBA
03/2014
1Carbon MonoxideIBA
05/2013
1InterleukinsIBA
04/2013
1Interleukin-4 (Interleukin 4)IBA
04/2013
1Interleukin-8 (Interleukin 8)IBA
04/2013
1Interleukin-10 (Interleukin 10)IBA
04/2013

Therapy/Procedure

1Drug Therapy (Chemotherapy)
10/2014
1Cesarean Section (Caesarean Section)
04/2013